A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 | 2462 | 2011 |
Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele PG Middleton, MA Mall, P Dřevínek, LC Lands, EF McKone, D Polineni, ... New England Journal of Medicine 381 (19), 1809-1819, 2019 | 1710 | 2019 |
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind … HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ... The Lancet 394 (10212), 1940-1948, 2019 | 1117 | 2019 |
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice C Castellani, H Cuppens, M Macek Jr, JJ Cassiman, E Kerem, P Durie, ... Journal of cystic fibrosis 7 (3), 179-196, 2008 | 881 | 2008 |
The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020 | 872 | 2020 |
VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1612-1620, 2018 | 671 | 2018 |
Guide to bone health and disease in cystic fibrosis RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005 | 569 | 2005 |
Tezacaftor–ivacaftor in residual-function heterozygotes with cystic fibrosis SM Rowe, C Daines, FC Ringshausen, E Kerem, J Wilson, E Tullis, N Nair, ... New England Journal of Medicine 377 (21), 2024-2035, 2017 | 525 | 2017 |
Recommendations for the classification of diseases as CFTR-related disorders C Bombieri, M Claustres, K De Boeck, N Derichs, J Dodge, E Girodon, ... Journal of Cystic Fibrosis 10, S86-S102, 2011 | 499 | 2011 |
Infection prevention and control guideline for cystic fibrosis: 2013 update L Saiman, JD Siegel, JJ LiPuma, RF Brown, EA Bryson, MJ Chambers, ... Infection Control & Hospital Epidemiology 35 (S1), s1-s67, 2014 | 456 | 2014 |
VX-659–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles JC Davies, SM Moskowitz, C Brown, A Horsley, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1599-1611, 2018 | 354 | 2018 |
Infection with Burkholderia cepacia in Cystic Fibrosis: Outcome Following Lung Transplantation C Chaparro, J Maurer, C Gutierrez, M Krajden, C Chan, T Winton, ... American journal of respiratory and critical care medicine 163 (1), 43-48, 2001 | 322 | 2001 |
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis K de Boer, KL Vandemheen, E Tullis, S Doucette, D Fergusson, A Freitag, ... Thorax 66 (8), 680-685, 2011 | 286 | 2011 |
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis V Waters, S Stanojevic, EG Atenafu, A Lu, Y Yau, E Tullis, F Ratjen European Respiratory Journal 40 (1), 61-66, 2012 | 280 | 2012 |
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis CY Ooi, R Dorfman, M Cipolli, T Gonska, C Castellani, K Keenan, ... Gastroenterology 140 (1), 153-161, 2011 | 280 | 2011 |
Insulin therapy to improve BMI in cystic fibrosis–related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial A Moran, P Pekow, P Grover, M Zorn, B Slovis, J Pilewski, E Tullis, ... Diabetes care 32 (10), 1783-1788, 2009 | 261 | 2009 |
Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis C Durno, M Corey, J Zielenski, E Tullis, LC Tsui, P Durie Gastroenterology 123 (6), 1857-1864, 2002 | 256 | 2002 |
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas N Ahmed, M Corey, G Forstner, J Zielenski, LC Tsui, L Ellis, E Tullis, ... Gut 52 (8), 1159-1164, 2003 | 230 | 2003 |
Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia KL Fraser, DE Tullis, Z Sasson, RH Hyland, KS Thornley, PJ Hanly Chest 115 (5), 1321-1328, 1999 | 213 | 1999 |
Infectious complications following isolated lung transplantation JR Maurer, DE Tullis, RF Grossman, H Vellend, TL Winton, GA Patterson Chest 101 (4), 1056-1059, 1992 | 211 | 1992 |